Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
veklury
Synonyms :
Nucleotide analog
Class :
Anti-virals, SARS-CoV-2
Dosage Forms & StrengthsÂ
Injection, lyophilized powderÂ
100mg/vialÂ
Injection, solutionÂ
100mg/20ml[5mg/ml]Â
Hospitalized patients:
Loading dose-Day 1: 200mg IV followed by
Maintenance dose- from Day 2: 100mg IV every day
Treatment duration:
Without ECMO/mechanical ventilation-5 days
With ECMO/mechanical ventilation-10 days
Non-hospitalized patients:
Loading dose-Day 1: 200mg IV followed by
Maintenance dose- from Day 2 to 5: 100mg IV every day
Dose Adjustments
Renal impairment
eGFR≥30ml/min-No dosage adjustment necessary
eGFR<30ml/min-Not recommended
Hepatic impairment
Uncertain if dosage modification is necessary
Injection, lyophilized powderÂ
100mg/vialÂ
Injection, solutionÂ
100mg/20ml[5mg/ml]Â
Hospitalized patients:
3kg to <40kg:
Loading dose-Day 1: 5mg /kg IV followed by
Maintenance dose- from Day 2: 2.5mg/kg IV every day
≥40 kgs:
Loading dose-Day 1: 200mg IV followed by
Non-hospitalized patients:
3kg to <40kg:
Loading dose-Day 1: 5mg/kg IV followed by
Maintenance dose- from Day 2 to 5: 2.5mg/kg IV on days 2-3
≥40 kgs:
Loading dose-Day 1: 200mg IV followed by
Maintenance dose- from Day 2: 100mg IV on days 2-3
may decrease the therapeutic effect of corticosteroids
may decrease the therapeutic effect of COVID-19
may decrease the therapeutic effect when combined with COVID-19 vaccines
may decrease the therapeutic effect when combined with COVID-19 vaccine
may decrease the therapeutic effect when combined with COVID-19 vaccine
may decrease the therapeutic effect when combined with COVID-19 vaccine
may have a decreased therapeutic effect when combined with covid-19 vaccine
may have a decreased therapeutic effect when combined with covid-19 vaccine
may have a decreased therapeutic effect when combined with covid-19 vaccine
may have a decreased therapeutic effect when combined with covid-19 vaccine
may have a decreased therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
CYP3A strong enhancers of the small intestine may reduce the bioavailability of remdesivir
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
may decrease the therapeutic effect when combined with covid-19 vaccine
Frequency defined:Â Â
>10%Â
Increased levels of creatinineÂ
Decreased creatinine clearanceÂ
Increased serum glucoseÂ
1-10%Â
NauseaÂ
LymphocytopeniaÂ
Decreased hemoglobinÂ
Prolonged prothrombin timeÂ
SeizureÂ
Hypersensitivity reactionsÂ
Skin rashÂ
Frequency undefinedÂ
AngioedemaÂ
Increased serum alkaline phosphataseÂ
Post-marketing reportsÂ
Acute hepatic failureÂ
AnaphylaxisÂ
BradycardiaÂ
Pregnancy consideration: Insufficient data is availableÂ
US FDA pregnancy category: Not assignedÂ
Lactation:Â Â
The excretion of drug in human breast milk is unknownÂ
Pregnancy category:Â
Patient information leafletÂ
Generic Name: RemdesivirÂ
Pronounced: (rem de’ si vir)Â
Why do we use remdesivir?Â
Remdesivir is used to treat patients who are tested positive for COVID-19, are either in or out of the hospital, have mild-to-moderate COVID-19, and are at high risk of developing severe COVID-19, which could result in hospitalization or death.Â